Receptos

RAPT Therapeutics

This biopharmaceutical company develops oral small-molecule therapies for patients with inflammatory diseases and cancer.

Pharmacyclics

This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.

Principia Biopharma

The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

ALMS

This biopharmaceutical company develops oral therapies to treat patients with immune-mediated diseases, neuroinflammatory conditions and neurodegenerative disorders.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Immunic Therapeutics

The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.